1. Home
  2. Downgrades

Downgrades

This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Scott Deuschle downgraded the rating for L3Harris Technologies, Inc. (NYSE:LHX) from Buy to Hold, but increased the price target from $245 […]

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst Adam Jonas downgraded the rating for General Motors Company (NYSE:GM) from Overweight to Equal-Weight, but increased the price target from $46 […]

CrowdStrike Faces Downgrades Amid Concerns Over Pricing and Renewals Following Disruption

CrowdStrike Holdings, Inc (NASDAQ:CRWD) stock continued its downward price trajectory Monday as its cloud software update on Thursday triggered an outage that affected businesses worldwide. A failed update to CrowdStrike’s Falcon platform disrupted Microsoft Corp (NASDAQ:MSFT) systems, halting critical global services, including airports, ports, financial institutions, and hospitals. Microsoft said the outage affected less than […]

This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst John Difucci downgraded the rating for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) from Buy to Neutral. CrowdStrike shares fell 11.1% to settle at $304.96 […]

Agenus Faces Regulatory and Financial Challenges: Analyst Downgrades Stock Pending Trial Clarity

Thursday, Agenus Inc. (NASDAQ:AGEN) announced the results of its end-of-Phase 2 meeting with the FDA to advance its immunotherapy combination, botensilimab (BOT) and balstilimab (BAL), for adult patients with relapsed/refractory microsatellite-stable colorectal cancer (r/r MSS CRC) with no active liver metastases (NLM). The FDA discouraged the accelerated approval pathway and advised against submitting these results to […]

This Sealed Air Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Andrew Wittmann downgraded the rating for Cintas Corporation (NASDAQ:CTAS) from Outperform to Neutral, while increasing the price target from $750 to $775. […]

BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.  The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend. In the second quarter, UnitedHealth Group Inc (NYSE:UNH) and Elevance Health reported increasing pressure on Medicaid, […]

1-800-Flowers Analyst Warns Bloomberg Debit Card Data Shows Unfavorable Trends

1-800-Flowers.Com Inc (NASDAQ:FLWS) stock closed Wednesday at $10.00 per share, down more than 9%. The company could miss the sales estimate for the fourth quarter of fiscal 2024 and issue its fiscal 2025 guidance below Street expectations, according to DA Davidson. The 1-800-Flowers Analyst: Linda Bolton Weiser downgraded coverage of 1-800-Flowers from Neutral to Underperform, […]